These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 2697406)
1. Post remission treatment in acute myelogenous leukaemia in first remission. The EORTC experience. EORTC Leukemia Cooperative Group. Willemze R; Zittoun R; Mandelli F; Tura S; de Witte T; Stryckmans P; Suciu S; Solbu G Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():72. PubMed ID: 2697406 [No Abstract] [Full Text] [Related]
2. Relative value of allogeneic BMT, autologous BMT and intensive chemotherapy during the first complete remission (CR) of acute myelogenous leukemia (AML). An interim analysis of the AML8 EORTC-GIMEMA protocol. Zittoun R; Mandelli F; De Witte T; Willemze R; Tura S Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():56-8. PubMed ID: 2202470 [No Abstract] [Full Text] [Related]
3. Post remission therapy in acute myeloid leukaemia (AML): the Medical Research Council experience in the UK. Rees JK; Gray RG Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():70-1. PubMed ID: 2697405 [No Abstract] [Full Text] [Related]
4. Methodology of evaluation in EORTC trials including BMT in acute myelogenous leukemia (AML) in first complete remission (CR). EORTC Leukemia Cooperative Group (LCG) and GIMEMA. Suciu S; Solbu G; Zittoun R; Hayat M; Willemze R; de Witte T; Mandelli F Bone Marrow Transplant; 1991; 7 Suppl 2():34. PubMed ID: 1878707 [No Abstract] [Full Text] [Related]
5. A randomized comparison of post-consolidation therapy in acute non-lymphoid leukaemia: a study of the Italian cooperative group GIMEMA. Petti MC; Mandelli F; Vegna ML; Broccia G; Carotenuto M; De Rosa F; Di Marco P; Di Raimondo F; Fioritoni G; Leone G Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():119-20. PubMed ID: 2653486 [No Abstract] [Full Text] [Related]
6. Treatment of acute myelogenous leukaemia. Löwenberg B J Intern Med Suppl; 1997; 740():17-22. PubMed ID: 9350177 [TBL] [Abstract][Full Text] [Related]
7. Autologous bone marrow transplantation in first remission AML--its relative value. de Gast GC; Zwaan FE; Hagenbeek T; Verdonck LF; Löwenberg B Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():52-4. PubMed ID: 2202468 [No Abstract] [Full Text] [Related]
8. Allogeneic versus autologous bone marrow transplantation (BMT) versus intensive consolidation in acute myelogenous leukemia (AML) in first remission. An EORTC-Gimema phase III trial (AML8 A). The EORTC Leukemia Cooperative Group and the GIMEMA Group. Zittoun R; Mandelli F; Willemze R; de Witte T; Tura S; Ferrini PR; Stryckmans P; Gattringer C; Petti MC; Solbu G Leukemia; 1992; 6 Suppl 2():114-5. PubMed ID: 1578909 [No Abstract] [Full Text] [Related]
9. Chemotherapy versus transplantation: I. Acute myelogenous leukemia. Gale RP; Butturini A Haematologica; 1989; 74(1):1-4. PubMed ID: 2498172 [No Abstract] [Full Text] [Related]
10. Comparison of intensive consolidation therapy and autologous bone marrow transplantation in acute myeloid leukaemia. The Leiden experience. Willemze R; Fibbe WE; Richel DJ; Kluin-Nelemans JC; Zwaan FE Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():73. PubMed ID: 2697407 [No Abstract] [Full Text] [Related]
11. Allogeneic and autologous bone marrow transplantation for patients with acute non-lymphoblastic leukemia in first complete remission. The Genoa experience on 119 patients. Carella AM; Piatti G; Frassoni F; Maraone MP; Van Lint MT; Bacigalupo A Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():55. PubMed ID: 2202469 [No Abstract] [Full Text] [Related]
12. Allogeneic marrow transplantation for acute non-lymphoblastic leukemia: first remission versus after first relapse. Buckner CD; Sanders J; Appelbaum FR Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():244-6. PubMed ID: 2653513 [No Abstract] [Full Text] [Related]
13. Clinical studies of allogeneic marrow transplantation in patients with acute non-lymphoblastic leukaemia. Seattle Marrow Transplant Team. Buckner CD; Clift RA Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():82. PubMed ID: 2697410 [No Abstract] [Full Text] [Related]
14. Results of autologous bone marrow transplantation for acute leukaemia. Gulati SC; Whitmarsh K; Reich L; Berman E; Yahalom J; Yopp J; Clarkson B; Gee T Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():61-4. PubMed ID: 2697438 [No Abstract] [Full Text] [Related]
15. [Comparison between intensive consolidation by bone marrow autograft or by chemotherapy of acute myeloblastic leukemias in 1st complete remission: AML8A protocol of the Leukemia Cooperative Group of the European Organization for Research and Treatment of Cancer (EORTC)]. Zittoun R; Rio B; Delmer A; Vekhof A; Mandelli F; Willemze R; de Witte T; Tura S; Ferrini PR; Stryckmans P Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):15-6. PubMed ID: 8511034 [No Abstract] [Full Text] [Related]
17. Treatment of acute myeloid leukaemia in first remission--chemotherapy versus bone marrow transplantation. De Witte T; De Pauw B; Holdrinet R; Janssen J; Haanen C Neth J Med; 1985; 28(7):281-4. PubMed ID: 3897880 [No Abstract] [Full Text] [Related]
18. Allogeneic BMT for AML in Zagreb. Labar B; Bogdanić V; Nemet D; Mrsić M; Pavletić Z; Zupancić S; Radman I; Aurer I Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():86-7. PubMed ID: 2697413 [No Abstract] [Full Text] [Related]
19. [Current situation and perspective for treatment of acute myelogenous leukemia in adults]. Fukushima T; Ueda T Gan To Kagaku Ryoho; 1998 Feb; 25(3):295-302. PubMed ID: 9492819 [TBL] [Abstract][Full Text] [Related]
20. Allogeneic versus autologous bone marrow transplantation versus intensive post-remission chemotherapy in acute leukaemias. Bernasconi C; Lazzarino M; Canevari A; Morra E; Castelli G; Brusamolino E; Alessandrino EP; Pagnucco G; Orlandi E; Castagnola C Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():65-8. PubMed ID: 2697439 [No Abstract] [Full Text] [Related] [Next] [New Search]